Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial

Potential Efficacy

A prospective study of FOLFOX4 regimen's tolerance in the treatment of metastatic colorectal cancer

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-869810 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

É Végh ◽

Á Petrányi ◽

K Tamas ◽

Z Szűcs ◽

G Bodoky

Keyword(s):

Colorectal Cancer ◽

Prospective Study ◽

A Prospective Study

Use of Array Comparative Genomic Hybridisation to Differentiate between Metastatic and Non-Metastatic Colorectal Cancer

Endoscopy ◽

10.1055/s-2006-956778 ◽

2006 ◽

Vol 38 (11) ◽

Author(s):

A Coss ◽

E Fox ◽

A Lloyd ◽

S Sullivan ◽

D O'Donoghue ◽

...

Keyword(s):

Colorectal Cancer ◽

Array Comparative Genomic Hybridisation

Comparative Genomic Hybridisation ◽

Comparative Genomic ◽

Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer

Experimental Oncology ◽

10.32471/exp-oncology.2312-8852.vol-42-no-4.15310 ◽

2020 ◽

Vol 42 (4) ◽

Keyword(s):

Colorectal Cancer ◽

Cytochrome P450 ◽

Liver Metastases ◽

Primary Tumors ◽

Cytochrome P450 Content

Deletions in metastatic colorectal cancer with chromothripsis

Experimental Oncology ◽

10.32471/exp-oncology.2312-8852.vol-41-no-4.13841 ◽

2019 ◽

Vol 41 (4) ◽

Author(s):

E.* Skuja ◽

◽

D. Butane ◽

M. Nakazawa-Miklasevica ◽

Z. Daneberga ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer

Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single centre prospective cohort study

Endocrine Abstracts ◽

10.1530/endoabs.41.gp110 ◽

2016 ◽

Author(s):

Fabiana Pani ◽

Laura Orgiano ◽

Francesco Boi ◽

Elena Massa ◽

Clelia Madeddu ◽

...

Keyword(s):

Colorectal Cancer ◽

Cohort Study ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Thyroid Dysfunction ◽

Single Centre ◽

Preliminary Results

The assessment of the ADC predictive value in survival outcomes of patients undergoing radiofrequency ablation for metastatic colorectal cancer liver tumors.

10.26226/morressier.59a6b34ad462b80290b55442 ◽

2017 ◽

Author(s):

Oliwia Kozak

Keyword(s):

Colorectal Cancer ◽

Radiofrequency Ablation ◽

Predictive Value ◽

Liver Tumors ◽

Survival Outcomes

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer

10.31525/ct1-nct03844620 ◽

2000 ◽

Author(s):

Keyword(s):

Colorectal Cancer ◽

Dna Testing ◽

Tumor Dna

Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer

10.31525/ct1-nct03880877 ◽

2019 ◽

Author(s):

Keyword(s):

Colorectal Cancer ◽

Previously Treated ◽

Irinotecan Dose

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

10.31525/ct1-nct03906565 ◽

2019 ◽

Author(s):

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Metastatic Colorectal Cancer

Genolimzumab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

10.31525/ct1-nct03977090 ◽

2019 ◽

Author(s):

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer